scholarly article | Q13442814 |
P2093 | author name string | Ollivier Legrand | |
Fanny Fava | |||
Jean-Pierre Marie | |||
Ruoping Tang | |||
Simona Lapusan | |||
Christophe Marzac | |||
Pierre Hirsch | |||
Irène Teyssandier | |||
Julia Pardo | |||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | leukemia | Q29496 |
P304 | page(s) | 2993-3000 | |
P577 | publication date | 2009-07-30 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia. | |
P478 | volume | 114 |
Q41170872 | ATF3 suppresses ESCC via downregulation of ID1. |
Q35193725 | ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients |
Q36595749 | Applying ecological and evolutionary theory to cancer: a long and winding road |
Q35854158 | Clinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemia |
Q49787877 | Consecutive epigenetically-active agent combinations act in ID1-RUNX3-TET2 and HOXA pathways for Flt3ITD+ve AML. |
Q90088711 | Deubiquitinases: Pro-oncogenic Activity and Therapeutic Targeting in Blood Malignancies |
Q36897128 | Differential role of Id1 in MLL-AF9-driven leukemia based on cell of origin. |
Q34773992 | E47 regulates hematopoietic stem cell proliferation and energetics but not myeloid lineage restriction |
Q92567745 | High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia |
Q64111646 | High expression of ID1 facilitates metastasis in human osteosarcoma by regulating the sensitivity of anoikis via PI3K/AKT depended suppression of the intrinsic apoptotic signaling pathway |
Q38913888 | ID helix-loop-helix proteins as determinants of cell survival in B-cell chronic lymphocytic leukemia cells in vitro |
Q54508849 | ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes. |
Q33897586 | IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study |
Q39402421 | Id-1 and the p65 subunit of NF-κB promote migration of nasopharyngeal carcinoma cells and are correlated with poor prognosis. |
Q26998811 | Molecular prognostic factors in cytogenetically normal acute myeloid leukemia |
Q35539865 | My what big eyes you have: how the Drosophila retina grows. |
Q37810969 | Older patients with acute myeloid leukemia |
Q36175739 | Physical and functional interaction between the ID1 and p65 for activation of NF-κB |
Q38183943 | Prognostic factors for acute myeloid leukaemia in adults--biological significance and clinical use. |
Q35717841 | Prognostic impact of high ABC transporter activity in 111 adult acute myeloid leukemia patients with normal cytogenetics when compared to FLT3, NPM1, CEBPA and BAALC |
Q37954583 | Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics |
Q34477821 | Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study |
Q35904946 | Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. |
Q34186326 | Regulation of the unfolded protein response by eif2Bdelta isoforms. |
Q33873915 | Small-molecule inhibitors of USP1 target ID1 degradation in leukemic cells. |
Q39871283 | Tgf-Beta superfamily receptors-targets for antiangiogenic therapy? |
Q39103288 | The Id-protein family in developmental and cancer-associated pathways. |
Q37895962 | Transcriptional and epigenetic regulation of B cell development |
Q36100455 | miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia |
Search more.